BIOLOGICAL · Unmapped registry intervention
filgrastim
Find medicine records ·
Find other trials using this name
Clinical trial
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005960
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
cyclophosphamide
Normalized identity: cyclophosphamideView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
doxorubicin hydrochloride
Normalized identity: doxorubicin hydrochlorideView linked drug · Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
pain therapy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCombination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Painunresolved
Prostate Cancerverified · MONDO: prostate cancer
Interventions
filgrastimBIOLOGICAL
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
docetaxelDRUG · verified · RxNorm: docetaxel
doxorubicin hydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride
pain therapyPROCEDURE
Sponsors & collaborators
Amgenlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00005960 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.